RedHill Biopharma Ltd. (RDHL)

7.00
0.04 0.57
NASDAQ : Health Technology
Prev Close 6.96
Open 6.99
Day Low/High 6.62 / 7.03
52 Wk Low/High 4.30 / 11.25
Volume 90.66K
Avg Volume 80.30K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 152.78M
EPS -2.60
P/E Ratio 26.77
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)